393 материалов по теме, собраны автоматически из проверенных источников
A single inherited EGFR mutation may increase lung cancer risk more than 60 times among individuals who never smoked. An evaluation of more than 3 million people showed the EGFR T790M variant increased risk for lung cancer 25 times overall, with a substantially larger impact on patients who reported never smoking…
MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer GlobeNewswire
A lung cancer treatment showed 90.5% disease control in an interim trial assessment stocktitan.net
Only about one in six U.S. adults eligible for lung cancer screening discussed the procedure with a health care professional in the past year, according to study results. Current smokers and those with comorbidities more often reported having those discussions, a finding researchers say suggests clinicians prioritize…
Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next Cure Today
How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation for Cancer Research Oncodaily
AbbVie’s Bet on Biology: Why One Modality Is Never Enough in Lung Cancer The Clinical Trial Vanguard
Ученые нашли препарат, который остановил рак легких с метастазами у 94% пациентов socportal.info
What happens to your lung cancer risk after you quit smoking? Oncologist explains | Health hindustantimes.com
AI imaging endpoint predicts OS benefit in phase III lung cancer trial: data presented at IASLC WCLC 2026 The Cancer Letter
First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale OncLive
Stage 3 Lung Cancer Injection Before Radiation: What Patients Need to Know Cure Today
Adopting Reflex Biomarker Testing to Improve Clinical Workflows for Patients With Non–Small Cell Lung Cancer HMP Global Learning Network
Young, Healthy, and Facing Stage 4 Lung Cancer American Lung Association